Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimatoprost for chemotherapy-induced eyelash hypotrichosis in Japanese subjects
NCT01391286Phase 3Completed
- Sponsor
- Allergan
- Start
- Jul 2011
- Primary completion
- May 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Eyelash Hypotrichosis comparing Bimatoprost 0.03% with Vehicle (2 arms). Primary endpoint: Percentage of Participants With at Least a 1-Grade Increase in Overall Eyelash Prominence Using the Global Eyelash Assessment Scale at Month 4. Started Jul 2011; status: completed.
02
Drugs
bimatoprost
03
Conditions
Eyelash Hypotrichosis
Beyond the preview
Go deeper on NCT01391286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01391286.